Stockscreener 앱 받기
2.35
6.82%
0.15
시간 외 거래:
2.32
-0.03
-1.28%
전일 마감가:
$2.20
열려 있는:
$2.24
하루 거래량:
2.22M
Relative Volume:
1.35
시가총액:
$332.63M
수익:
-
순이익/손실:
$-35.47M
주가수익비율:
-4.1228
EPS:
-0.57
순현금흐름:
$-124.27M
1주 성능:
+8.29%
1개월 성능:
+4.44%
6개월 성능:
+173.92%
1년 성능:
+27.03%
1일 변동 폭
$2.21
$2.3953
1주일 범위
$2.06
$2.3953
52주 변동 폭
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
명칭
Prokidney Corp
전화
336-999-7028
주소
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
PROK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.35 | 311.40M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | H.C. Wainwright | Buy |
| 2025-06-30 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-09-30 | 개시 | JP Morgan | Neutral |
| 2024-09-10 | 개시 | Guggenheim | Buy |
| 2024-03-07 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-07-25 | 개시 | BTIG Research | Buy |
| 2022-12-21 | 개시 | Jefferies | Buy |
| 2022-11-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-10-18 | 개시 | UBS | Buy |
| 2022-10-14 | 개시 | Citigroup | Buy |
| 2022-09-23 | 개시 | BofA Securities | Buy |
| 2022-09-02 | 개시 | Evercore ISI | Outperform |
모두보기
Prokidney Corp 주식(PROK)의 최신 뉴스
ProKidney (NASDAQ:PROK) Stock Price Up 5.2%What's Next? - MarketBeat
ProKidney (NASDAQ:PROK) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Truliant, ProKidney sales top Triad commercial transactions for week of Dec. 12 - The Business Journals
HC Wainwright & Co. Initiates Coverage of ProKidney (PROK) with Buy Recommendation - Nasdaq
H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target By Investing.com - Investing.com South Africa
ProKidney initiated with a Buy at H.C. Wainwright - TipRanks
HC Wainwright Initiates Coverage on ProKidney With Buy Rating, $12 Price Target - marketscreener.com
H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target - Investing.com India
ProKidney Corp. (NASDAQ:PROK) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
ProKidney (NASDAQ:PROK) Trading Down 6.8%What's Next? - MarketBeat
Why ProKidney Corp. stock remains resilientJuly 2025 Earnings & Real-Time Volume Analysis - Newser
Promising Penny Stocks To Watch In December 2025 - simplywall.st
ProKidney Shares Dip Following FDA Agreement on Rilparencel Approval Strategy - MSN
What drives ProKidney Corp stock priceCurrency Fluctuation Impact & Rapid Capital Trading Tips - earlytimes.in
ProKidney site sells Greensboro site for $6.5M less than it paid for property - The Business Journals
While insiders own 18% of ProKidney Corp. (NASDAQ:PROK), retail investors are its largest shareholders with 50% ownership - Yahoo Finance
ProKidney Corp. (PROK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How ProKidney Corp. stock benefits from tech adoptionWeekly Volume Report & Smart Money Movement Alerts - newser.com
Will ProKidney Corp. stock beat EPS estimatesMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
What data driven models say about ProKidney Corp.’s futureQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
What technical charts say about ProKidney Corp. stockJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
What valuation multiples suggest for ProKidney Corp. stockJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
Is now a turning point for ProKidney Corp.Recession Risk & Fast Entry Momentum Trade Alerts - newser.com
What sentiment indicators say about ProKidney Corp. stock2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - newser.com
[EFFECT] PROKIDNEY CORP. SEC Filing - Stock Titan
Automated trading signals detected on ProKidney Corp.Market Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Will ProKidney Corp. stock recover faster than peersDollar Strength & AI Enhanced Trading Alerts - newser.com
Greensboro ProKidney site sells for $19.1M - Greensboro News and Record
What to expect from ProKidney Corp. in the next 30 daysQuarterly Investment Review & Daily Growth Stock Tips - newser.com
ProKidney Corp. (NASDAQ:PROK) Receives Average Rating of "Hold" from Analysts - MarketBeat
Brian Jg Pereira Sells 255,026 Shares of ProKidney (NASDAQ:PROK) Stock - MarketBeat
Insider Selling: ProKidney (NASDAQ:PROK) Director Sells 502,136 Shares of Stock - MarketBeat
Will ProKidney Corp. stock go up soonWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
What candlestick patterns are forming on ProKidney Corp.2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
Is ProKidney Corp. stock poised for growthJuly 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
ProKidney Independent Director Brian Jude Pereira Sells 100% Of Holding - simplywall.st
Visual analytics tools that track ProKidney Corp. performance2025 Retail Activity & AI Driven Price Forecasts - newser.com
Heatmap analysis for ProKidney Corp. and competitorsInflation Watch & Risk Adjusted Swing Trade Ideas - newser.com
How ProKidney Corp. stock performs in stagflationMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
Prokidney Corp (PROK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):